Lynparza
Lynparza ingredients
| Active ingredient | Strength |
|---|---|
| Olaparib | 100 mg/1, 150 mg/1 |
What Lynparza is used for
The FDA lists the approved uses on the official label (below). In the EU, olaparib is approved as Lynparza for:
Ovarian cancer Lynparza is indicated as monotherapy for the: maintenance treatment of adult patients with advanced (FIGO stages III and IV) BRCA1/2-mutated (germline and/or somatic) high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. maintenance treatment of adult patients with platinum sensitive relapsed high grade epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum based chemotherapy. Lynparza in combination with bevacizumab is indicated for the: maintenance treatment of adult patients with advanced (FIGO stages III and IV) high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemo…
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Lynparza
- Generic name
- Olaparib
- Made by
- AstraZeneca Pharmaceuticals LP
- Forms
- Tablet, Film Coated
- Given
- Oral
- Drug class
- Poly(ADP-Ribose) Polymerase Inhibitor
- FDA approval
- New drug application (NDA) NDA208558
- On the US market since
- 2017
Official information
- Lynparza prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Olaparib)
In India
- Olaparib: 3 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Lynparza?
Lynparza (Olaparib) is a cancer medicine made by AstraZeneca Pharmaceuticals LP, approved by the US FDA.
What are the ingredients of Lynparza?
Lynparza contains Olaparib (100 mg/1, 150 mg/1).
Is Lynparza approved in Europe?
The same active substance is approved in the EU as Lynparza.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA